Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-25

Clinical Trial Update: Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a tenofovir-based regimen (tenofovir disoproxil fumarate with lamivudine and efavirenz) to a stavudine-based regimen (stavudine with l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (lamivudine) (lamivudine)
  • Sustiva (efavirenz) (efavirenz)
  • Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)
  • Zerit (stavudine) (stavudine)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 3 | Status: COMPLETED